Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

386476

registered interest
date	30/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Liver Diseases
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government when Public Health England's programme of work on liver disease will be published.
tabling member printed	Baroness Randerson
uin	HL971
answer	answer is ministerial correction date of answer 09/07/2015 answer text <p>Public Health England’s liver disease framework will be published in autumn 2015.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 09/07/2015 12:59:16 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	4230 label Biography information for Baroness Randerson

385300

registered interest
date	24/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Liver Diseases
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether the programme of work for liver disease being developed by Public Health England will include a hepatitis C improvement framework.
tabling member printed	Baroness Masham of Ilton
uin	HL783
answer	answer is ministerial correction date of answer 08/07/2015 answer text <p>NHS England and Public Health England (PHE) are working alongside a coalition of other organisations and patient groups to draft a framework for hepatitis C improvement. This hepatitis C improvement framework will set high level aims for the public health system towards elimination of hepatitis C related liver disease as a significant public health concern.</p><p> </p><p> </p><p> </p><p>The hepatitis C improvement framework will be referred to in PHE’s liver disease framework.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 08/07/2015 14:54:40 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	1850 label Biography information for Baroness Masham of Ilton

228729

registered interest
date	19/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Liver Diseases
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what steps they are taking to ensure that people suffering from Lysosomal Acid Lipase Deficiency and other causes of cirrhosis in children are diagnosed as soon as possible and have a suitable route to commissioning that is as streamlined and effective as possible.
tabling member printed	Baroness Masham of Ilton
uin	HL5911
answer	answer is ministerial correction date of answer 26/03/2015 answer text <p>The UK Strategy for Rare Diseases commits all four countries of the United Kingdom to work to achieve reduced times for diagnosis of rare diseases and to work with the National Health Service and clinicians to establish appropriate diagnostic pathways which are accessible to, and understood by, professionals and patients.</p><p> </p><p> </p><p> </p><p>NHS England commissions a highly specialised service for liver disease in children, including cirrhosis resulting from lysosomal acid lipase, from three expert centres in London, Birmingham and Leeds. These long established centres provide a clear referral pathway for expert diagnosis and management.</p> answering member printed Earl Howe question first answered 26/03/2015 12:51:28 answering member 2000 label Biography information for Earl Howe
tabling member	1850 label Biography information for Baroness Masham of Ilton

222554

registered interest
date	20/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Liver Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to improve diagnosis of hepatic encephalopathy.
tabling member constituency	Caerphilly
tabling member printed	Wayne David
uin	224619
answer	answer is ministerial correction date of answer 25/02/2015 answer text <p>Hepatic encephalopathy is an important end stage complication of liver disease. Monitoring at a national level is difficult because there is no specific code in the 10th edition of the International Classification of Diseases system (ICD10). The ICD10 guide recommends that patients with hepatic encephalopathy are classified as K72.9; hepatic failure, un-specified. Public Health England is working on raising the profile of hepatic encephalopathy with the Lancet Commission.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 25/02/2015 15:53:14 answering member 3918 label Biography information for Jane Ellison
tabling member	1398 label Biography information for Wayne David

222555

registered interest
date	20/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Liver Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, for what reasons the strategy for combating liver disease referred to by the Prime Minister on the 10 Downing Street website on 28 July 2011 has not been published.
tabling member constituency	Caerphilly
tabling member printed	Wayne David
uin	224620
answer	answer is ministerial correction date of answer 25/02/2015 answer text <p>Whilst NHS England is responsible for the overall national approach to improving clinical outcomes for people with liver disease, Public Health England (PHE) is working with the Lancet Commission on Liver Disease. This work involves regular meetings with Professor Richard Williams, (Lead, Lancet Standing Commission into Liver Disease in the UK), and attending action planning meetings.</p><p> </p><p> </p><p> </p><p>PHE is working with NHS England and liver charities to respond to the key recommendations of the Lancet Commission and will produce a Liver Disease Framework in summer 2015 outlining the scope of its activities.</p><p> </p><p> </p><p> </p><p>This will cover PHEs extensive programme of activities to tackle the three main risk factors for liver disease: alcohol, obesity and Hepatitis B &amp; C; work with the Lancet Commissioners and GPs to strengthen detection and interventions for early stage liver disease and for identification of high risk patients; support a national needs assessment for liver disease services in the NHS.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 224621 question first answered 25/02/2015 17:59:33 answering member 3918 label Biography information for Jane Ellison
tabling member	1398 label Biography information for Wayne David

222556

registered interest
date	20/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Liver Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to implement the recommendations of the Lancet Commission report on liver disease, published on 27 November 2014.
tabling member constituency	Caerphilly
tabling member printed	Wayne David
uin	224621
answer	answer is ministerial correction date of answer 25/02/2015 answer text <p>Whilst NHS England is responsible for the overall national approach to improving clinical outcomes for people with liver disease, Public Health England (PHE) is working with the Lancet Commission on Liver Disease. This work involves regular meetings with Professor Richard Williams, (Lead, Lancet Standing Commission into Liver Disease in the UK), and attending action planning meetings.</p><p> </p><p> </p><p> </p><p>PHE is working with NHS England and liver charities to respond to the key recommendations of the Lancet Commission and will produce a Liver Disease Framework in summer 2015 outlining the scope of its activities.</p><p> </p><p> </p><p> </p><p>This will cover PHEs extensive programme of activities to tackle the three main risk factors for liver disease: alcohol, obesity and Hepatitis B &amp; C; work with the Lancet Commissioners and GPs to strengthen detection and interventions for early stage liver disease and for identification of high risk patients; support a national needs assessment for liver disease services in the NHS.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 224620 question first answered 25/02/2015 17:59:34 answering member 3918 label Biography information for Jane Ellison
tabling member	1398 label Biography information for Wayne David

175569

registered interest
date	26/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Liver Diseases
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what steps they are taking to improve care and treatment for patients with hepatic encephalopathy.
tabling member printed	Lord Avebury
uin	HL4412
answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>NHS England, Public Health England (PHE) and the Department of Health are working jointly with stakeholders to make sure that patients with liver disease, including those who may develop hepatic encephalopathy, are supported. PHE is also working with stakeholders to develop a liver disease framework.</p><p> </p><p> </p><p> </p><p>There are currently no plans to carry out a clinical audit into services for people with advanced liver disease for all causes. However, liver cancer outcomes for the specialised services which NHS England commissions are currently audited and a national audit of outcome dimensions for the treatment of hepatitis C will be established by NHS England in due course. In addition, PHE is working with the Lancet Commission on Liver Disease to use routine data to investigate elements of care for people with advanced liver disease.</p><p> </p><p> </p><p> </p><p>We are also taking action to prevent people developing liver disease in the first place by tackling two of the main causes of liver disease – obesity and alcohol misuse. This includes:</p><p> </p><p> </p><p> </p><p>- our Call to Action on Obesity, which sets out two national ambitions for a downward trend in level of excess weight in children and adults by 2020; and</p><p> </p><p> </p><p> </p><p>- our Alcohol Strategy, which aims to cut the number of people drinking above the lower-risk guidelines.</p><p> </p> answering member printed Earl Howe grouped question UIN HL4413 question first answered 03/02/2015 13:55:48 answering member 2000 label Biography information for Earl Howe
tabling member	1665 label Biography information for Lord Avebury

175570

registered interest
date	26/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Liver Diseases
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether they have plans to work with NHS England to ensure that a clinical audit is carried out into services for people with advanced liver disease from all causes.
tabling member printed	Lord Avebury
uin	HL4413
answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>NHS England, Public Health England (PHE) and the Department of Health are working jointly with stakeholders to make sure that patients with liver disease, including those who may develop hepatic encephalopathy, are supported. PHE is also working with stakeholders to develop a liver disease framework.</p><p> </p><p> </p><p> </p><p>There are currently no plans to carry out a clinical audit into services for people with advanced liver disease for all causes. However, liver cancer outcomes for the specialised services which NHS England commissions are currently audited and a national audit of outcome dimensions for the treatment of hepatitis C will be established by NHS England in due course. In addition, PHE is working with the Lancet Commission on Liver Disease to use routine data to investigate elements of care for people with advanced liver disease.</p><p> </p><p> </p><p> </p><p>We are also taking action to prevent people developing liver disease in the first place by tackling two of the main causes of liver disease – obesity and alcohol misuse. This includes:</p><p> </p><p> </p><p> </p><p>- our Call to Action on Obesity, which sets out two national ambitions for a downward trend in level of excess weight in children and adults by 2020; and</p><p> </p><p> </p><p> </p><p>- our Alcohol Strategy, which aims to cut the number of people drinking above the lower-risk guidelines.</p><p> </p> answering member printed Earl Howe grouped question UIN HL4412 question first answered 03/02/2015 13:55:48 answering member 2000 label Biography information for Earl Howe
tabling member	1665 label Biography information for Lord Avebury

174744

registered interest
date	20/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Liver Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to support patients with cirrhosis liver conditions.
tabling member constituency	Upper Bann
tabling member printed	David Simpson
uin	221356
answer	answer is ministerial correction date of answer 27/01/2015 answer text <p>NHS England, Public Health England (PHE) and the Department are working jointly with stakeholders to make sure that patients with liver disease, including cirrhosis, are supported. This work includes taking forward the recommendations of the recent Lancet Commission report on liver disease in the United Kingdom. In addition, PHE is working with stakeholders to develop a liver disease framework.</p><p> </p><p> </p><p> </p><p>We are also taking action to prevent people developing liver disease in the first place by tackling two of the main causes of liver disease – obesity and alcohol misuse. This includes:</p><p> </p><p> </p><p> </p><p>- our Call to Action on Obesity, which sets out two national ambitions for a downward trend in level of excess weight in children and adults by 2020;</p><p> </p><p>- our Alcohol Strategy, which aims to cut the number of people drinking above the lower-risk guidelines; and</p><p> </p><p>- PHE’s five outcome focussed priorities which includes helping people to live longer and more healthy lives by reducing preventable deaths and the burden of ill health associated with, amongst others, alcohol.</p><p> </p><p><strong> </strong></p><p> </p><p>In addition, the National Institute for Health and Care Excellence is developing clinical guidance on the assessment and management of cirrhosis. The guidance is due to be published in May 2016.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/01/2015 12:32:11 answering member 3918 label Biography information for Jane Ellison
tabling member	1597 label Biography information for David Simpson

171813

registered interest
date	02/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Liver Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to support the early identification of liver disease.
tabling member constituency	Cheadle
tabling member printed	Mark Hunter
uin	219598
answer	answer is ministerial correction date of answer 09/01/2015 answer text <p>Public Health England (PHE) has a comprehensive range of action aimed at reducing the incidence and mortality from liver disease. It monitors the incidence, mortality and outcomes of treatment for liver disease and the risk factors: alcohol obesity and hepatitis B and C. PHE has a wide range of action to tackle unhealthy alcohol consumption, obesity and viral hepatitis through strengthening local action, promoting healthy choices, and giving appropriate information to support healthier lives.</p><p> </p><p> </p><p> </p><p>In response to the All Party Parliamentary Hepatology Group report PHE has committed to producing a PHE Liver Disease Framework. This will focus on public health action to tackle risk factors for liver disease and inequalities in relation to liver disease. Work has already begun to bring together expertise within PHE on the major risk factors for liver disease (alcohol, hepatitis B and C and obesity), data on liver disease and its risk factors and on death and dying from liver disease. PHE has also issued liver profiles to each local authority area, which include information about hepatitis C, as well as modelling tools to assist local commissioners in establishing need at local level. Many of the actions to tackle the major risk factors require a coordinated approach between PHE and NHS England.</p><p> </p><p> </p><p> </p><p>NHS England is responsible for delivering improvements in outcomes against the NHS Mandate and in line with the NHS Outcomes Framework. NHS England is adopting a broad strategy for delivering improvements in relation to premature mortality, working with commissioners and PHE to support clinical commissioning groups in understanding where local challenges lie and in identifying the evidence in relation to the priorities for reducing mortality at a national level.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/01/2015 13:38:47 answering member 3918 label Biography information for Jane Ellison
tabling member	1598 label Biography information for Mark Hunter